Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors
US-11639355-B2 · May 2, 2023 · US
Shandong Luoxin Pharmacy Stock holds 5 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 5 |
| Recent patents | 0 |
| First publication | Oct 24, 2017 |
| Latest publication | May 2, 2023 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-11639355-B2 · May 2, 2023 · US
US-2021230164-A1 · Jul 29, 2021 · US
US-10316033-B2 · Jun 11, 2019 · US
US-2018079749-A1 · Mar 22, 2018 · US
US-9796732-B2 · Oct 24, 2017 · US
Representative or frequently cited publications from precomputed assignee stats.
US-11639355-B2 · May 2, 2023 · US
US-2021230164-A1 · Jul 29, 2021 · US
US-10316033-B2 · Jun 11, 2019 · US
US-2018079749-A1 · Mar 22, 2018 · US
US-9796732-B2 · Oct 24, 2017 · US
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 5 |
| Human Necessities | 3 |
Answers are generated from the same data shown on this page.